|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
|
|
|
|
€ 400,00 |
Editeur
: |
Rocsearch |
Langue
: |
Anglais |
Date de publication : |
Avril 2003 |
Taille du document : |
20 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Nanotechnology: Emerging Trends
30 pages | Avril 2003 |
Recently, nanotechnology has become extremely popular and is used to describe many types of research where the characteristic dimensions are less than about 1,000 nanometers.
Nanotechnology also pr |
550,00 €
|
| |
| |
Combinatorics IRCD
pages | Juillet 2001 |
Identified by The Economist (*) as the industry to watch for 1997 in the chemicals sector, Combinatorics (also known as combinatorial chemistry) is an emerging platform technology that uses test t |
1 200,00 €
|
| |
| |
03-052A: Protein Purification Systems: Market Opportunities for Research Product Suppliers
163 pages | Octobre 2003 |
This report will help suppliers exploit opportunities to differentiate themselves from their competitors and develop more advanced protein purification tools |
960,00 €
|
| |
| |
Functional Proteomics and Emerging Bio-IT market
pages | Novembre 2002 |
The proteomic technique is not only limited to the study of one or few cellular products but also allows for qualitative and a quantitative measurement of several hundreds of proteins produced during |
250,00 €
|
| |
| |
Outsourcing in the Biotech Indsutry
20 pages | Juillet 2002 |
Outsourcing is revolutionising the biotech industry.
Companies have realised that with outsourcing, they can utilise their synergies and work together to deliver products at a faster rate.
The e |
400,00 €
|
| |
| |
Combinatorics
150 pages | Décembre 2000 |
Identified by The Economist (*) as the industry to watch for 1997 in the chemicals sector, Combinatorics (also known as combinatorial chemistry) is an emerging platform technology that uses test t |
1 400,00 €
|
| |
| |
Arthritis Drug Discovery IRCD
pages | Juin 2001 |
Arthritis (from the Greek for joint) is a chronic multi-factorial disease of the joints, induced when the immune system attacks and begins degrading the joints.
The disease knows no racial boun |
1 026,17 €
|
| |
| |
The Biotechnology Industry in US & Europe
22 pages | Mai 2002 |
A new report by RocSearch, The Biotechnology Industry in US & Europe, gives an overview of the global biotechnology industry.
It emphasizes current and emerging technologies including monoclonal an |
500,00 €
|
| |
| |
The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets
150 pages | Janvier 2002 |
Genomics is quietly transforming the pharmaceutical industry.
Companies are moving from medicinal chemistry based drug discovery and development, to using information provided by genomics.
V |
953,48 €
|
| |
| |
Bioinformatics
150 pages | Décembre 2000 |
Automation has assaulted several levels of biological research generating vast amounts of data.
Great leaps in DNA sequencing technology and automation led to a dramatic increase in sequence th |
1 400,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Genetic testing interests the companies and the government alike. Companies are racing to understand and tap the mass of information pouring out of the Human Genome Project. It is raising hopes in the mind of people that in future all the diseases will be curable.
This report takes a comprehensive look at the technological developments resulting from the genome project.It discuss genomics and proteomics in detail. The market trends are discussed along with the profiles of leading companies. In addition, the federal and state policies, legal aspects and the concept of designer babies has been discussed along with the future outcomes.
|
|
|
PPLSEN
|
|
|
|
|
